Discovery of novel tricyclic 5H-Pyridazino[4,5-b]indoles as potent antitumor agents: Design, synthesis and biological evaluation

Abstract

A novel series of 5H-pyridazino[4,5-b]indoles(L-01—L-32) was synthesized and characterized by means of 1H NMR, MS and elemental analysis. The cytotoxicity of the target compounds against Bel-7402 and HT-1080 cell lines were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assay. Most of them exhibited moderate to excellent cytotoxicity, and six compounds(L-04, L-06, L-18, L-20, L-21 and L-23) possessed dramatically increased cytotoxicity superior to Gefitinib. Of these initial hits, compound L-21 displayed remarkable cytotoxicity against the tested cell lines with half maximal inhibitory concentration(IC₅₀) values of 4.6 and 2.1 μmol/L, respectively, which was 13.9- to 25.6-fold more potent than positive control.

Keywords

1-Anilino-5H-pyridazino[4,5-b]indole / EGFR inhibitor / Cytotoxicity

References

[1] Sriram M., Hall J. J., Grohmann N. C., Strecker T. E., Wootton T., Franken A., Trawick M. L., Pinney K. G. Bioorg. Med. Chem., 2008, 16: 8161.

[2] Peifer C., Krasowski A., Hämmerle N., Kohlbacher O., Dannhardt G., Totzke F., Schächtele C., Laufer S. J. Med. Chem., 2006, 49: 7549.

[3] Ishida J., Wang H. K., Bastow K. F., Hu C. Q., Lee K. H. Bioorg. Med. Chem. Lett, 1999, 9: 3319.

[4] Song Y., Wang J., Teng S. F., Kesuma D., Deng Y., Duan J., Wang J. H., Qi R. Z., Sim M. M. Bioorg. Med. Chem. Lett, 2002, 12: 1129.

[5] Palmer B. D., Trumpp-Kallmeyer S., Fry D. W., Nelson J. M., Showalter H. D., Denny W. A. J. Med. Chem., 1997, 40: 1519.

[6] Rewcastle G. W., Palmer B. D., Bridges A. J., Showalter H. D., Sun L., Nelson J., McMichael A., Kraker A. J., Fry D. W., Denny W. A. J. Med. Chem., 1996, 39: 918.

[7] Cao R., Peng W., Chen H., Ma Y., Liu X., Hou X., Guan H. Biochem. Biophys. Res. Commun., 2005, 338: 1557.

[8] Schmitt C., Kail D., Mariano M., Empting M., Weber N., Paul T., Hartmann R. W., Engel M. PLoS One, 2014, 9: 87851.

[9] Li R. D., Zhai X., Zhao Y. F., Gong P. Chin. Chem. Lett., 2007, 18: 1191.

[10] Zhao Y. F., Dong J. H., Gong P. Chin. Chem. Lett., 2004, 15: 1039.

[11] Kalir A. Org. Synth., Coll, 1973, 5: 825.

[12] Hennequin L. F., Stokes E. S., Thomas A. P., Johnstone C., Plé P. A., Ogilvie D. J., Dukes M., Wedge S. R., Kendrew J., Curwen J. O. J. Med. Chem., 2002, 45: 1300.

[13] Heaney H., Papageorgiou G., Wilkins R. F. Tetrahedron Lett., 1988, 29: 2377.

[14] Guo S. C., Zhao Y. F., Li R. D., Xie L. J., Yang Y. B., Gong P. Chem. Res. Chinese Universities, 2008, 24(1): 47.